Holen Sie sich die Stockscreener-App
5.405
0.64%
-0.035
Handel nachbörslich:
5.30
-0.105
-1.94%
Endra Life Sciences Inc Aktie (NDRA) Neueste Nachrichten
ENDRA (NASDAQ: NDRA) weighs shift into South African helium - Stock Titan
ENDRA Life Sciences (NASDAQ: NDRA) shares ASP Isotopes helium plant update - Stock Titan
ENDRA (NDRA) Price: Moves 0.22% Lower to $4.50 on the Day; Boundary Watch: $4.27 and $4.73 Define the Nearby Reference Levels at the CloseSentiment Extreme - vinanet.vn
ENDRA Life Sciences Swings To Q2 Profit On Digital Asset Gains Ahead Of Noble Africa Merger - Pulse 2.0
ENDRA Life Sciences (NDRA) Holds Above Support, Edges Up 0.45% to $4.49Up Down Volume - dars.gov.et
ENDRA to merge with Noble Africa, pivoting to helium in $50M-backed deal - Dealroom
ENDRA Life Sciences (Nasdaq: NDRA) shares Q2 2026 earnings update - Stock Titan
ENDRA Life Sciences Reports $159,944 Second-Quarter 2026 Net Income - Moomoo
Crypto lifts ENDRA (NASDAQ: NDRA) to Q2 profit amid pending Noble Africa deal - Stock Titan
Endra Life Sciences reported Q2 net income $160,000 vs $1.2M last year - TipRanks
ENDRA (NDRA) Q2 2026 Cash Position Highlights Challenges Amid Un - GuruFocus
ENDRA Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Update - mykxlg.com
ENDRA Life Sciences posts Q2 profit on digital asset gains ahead of merger - TradingView
NDRA Q1 2026 Earnings: Wider-Than-Expected $1.80 Per Share Loss Highlights Pre-Revenue Cost PressuresPretax Income Report - vinanet.vn
ENDRA Life Sciences (NDRA) Holds Steady at $4.47 Amid ConsolidationSector Sentiment - dars.gov.et
ENDRA Life Sciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView
ENDRA Life Sciences (NDRA) swings to Q2 profit, raises $3.8M and outlines Noble Africa merger - Stock Titan
NDRA Q2'26 Earnings: EPS estimate is (0.84) USD - TradingView
NDRA Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
ENDRA Life Sciences Inc expected to post a loss of 84 cents a shareEarnings Preview - TradingView
ENDRA Life Sciences Inc (NDRA) Stock News Today - TradingKey
ENDRA Life Sciences Inc (NDRA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
NDRA Q1 2026 Earnings: Wider-than-Expected Loss Highlights Early-Stage ChallengesEarnings Per Share - vinanet.vn
ASP Isotopes Inc. (NASDAQ: ASPI) notes new LNG sales deal at Virginia Gas Project - Stock Titan
ASP Isotopes Inc. (NDRA) to host investor meetings at Citi 2026 Natural Resources Conference - Stock Titan
NDRA Q1 2026 Earnings: Wider-Than-Expected Loss, Yet Shares Surge 8.55%Share Dilution Risk - dars.gov.et
NDRA Q1 2026 Earnings: Wider-than-Expected Loss Meets Positive Share Price MomentumEarnings Quality Score - vinanet.vn
ENDRA Life Sciences Inc (NDRA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
ASP Isotopes to Detail Nuclear Medicine, Fuels at Sept. 8 Event - Stock Titan
ENDRA Life Sciences Inc (NDRA) Balance Sheet - TradingKey
ENDRA Life Sciences Inc (NDRA) Cash Flow - TradingKey
ENDRA Life Sciences Inc (NDRA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
NDRA|ENDRA Life Sciences Inc|Price:4.750|Chg%:-0.110 - TradingKey
ENDRA Life Sciences Inc (NDRA) Earnings Date & Reports & Earnings News - TradingKey
ENDRA Life Sciences Inc (NDRA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
ENDRA Life Sciences Inc. Revenue Breakdown – NASDAQ:NDRA - TradingView
ENDRA Life Sciences Inc (NDRA) Valuation: PE, PB & Fair Value Analysis - TradingKey
ENDRA Life Sciences Inc (NDRA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TradingKey - TradingKey
NDRA|ENDRA Life Sciences Inc|Price:4.860|Chg%:-0.370 - TradingKey
ENDRA Life Sciences Inc (NDRA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
ENDRA Life Sciences (NDRA) Advances 4.66% as Shares Test Resistance Near $5.89Fundamental Weighted - dars.gov.et
ENDRA Life Sciences (NDRA) News Flow - Moomoo
ENDRA Life Sciences Inc (NDRA) Fundamental & Financial Data - Stocktwits
Noble Africa-ENDRA (NDRA) merger to create pure-play helium and LNG company - Stock Titan
ASP Isotopes (NDRA) outlines Noble Africa–ENDRA merger and $750M project funding - Stock Titan
ASP Isotopes maps Noble Africa listing as helium project nears production - MSN
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Join the Live Investor Webinar for Noble Africa, the Proposed ASP Isotopes Spin-Out Creating a Public Helium Company - marketscreener.com
Frontier tech research, news & data - MLQ.ai
ENDRA Life Sciences agrees to merge with ASP Isotopes unit Noble Africa in deal set to create Nasdaq-listed NOBA - Bitget
ASP Isotopes and ENDRA (NASDAQ: NDRA) plan Noble Africa helium spin-out - Stock Titan
ENDRA Life Sciences (NASDAQ: NDRA) details Noble Africa merger and helium strategy - Stock Titan
Noble Africa's helium project could become a Nasdaq-listed company - Stock Titan
NDRA Q1 2026 Earnings: Wider-than-Expected Loss as Pre-Revenue Biotech Continues R&DFinancial Summary - vinanet.vn
NDRA Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Faces ChallengesTax Rate Impact - vinanet.vn
NDRA Q1 2026 Earnings: Wider-than-Expected Loss Amid No Revenue, Stock Rises SlightlyOperating Margin Analysis - DonanımHaber
ENDRA Life Sciences (NDRA) Files 8-K Report: Company Information, NASDAQ Listing, and Corporate Details - Minichart
ENDRA Regains Nasdaq Compliance, Enters One-Year Monitoring - TipRanks
END regains Nasdaq compliance but faces one-year discretionary panel monitoring - TradingView
ENDRA Life Sciences (NASDAQ: NDRA) regains Nasdaq listing compliance but faces review - Stock Titan
NDRA Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Faces Headwinds - dars.gov.et
ENDRA Life Sciences Q1 2026 Earnings: Wider-than-Expected Loss as Pre-Revenue Stage ContinuesTangible Book Value - dars.gov.et
SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--FSRL, SYNA, TECH, and NDRA - Sahm
NDRAENDRA Life Sciences Inc Latest SEC Filings - Finviz
ENDRA Life Sciences (NDRA) Stock Analysis Report | Financials & Insights - Benzinga España
0.24%
1.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):